Rezolute (RZLT) Other Working Capital Changes (2018 - 2026)
Rezolute (RZLT) posted Other Working Capital Changes of -$349000.0 for Q1 2026, up 25.11% sequentially from -$466000.0 in Q4 2025, and down 60.83% YoY from -$890976.5 in Q1 2025.
Analysis
Rezolute (RZLT) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Rezolute has reported Other Working Capital Changes for 15 years, with the latest figure at -$349000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 60.83% year-over-year to -$349000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$545000.0 (down 175.38% YoY) and the FY2025 annual result came in at $2.1 million, up 1524.03% from the prior year.
- Other Working Capital Changes rose to -$349000.0 in Q1 2026 per RZLT's latest filing, from -$466000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.6 million in Q1 2023 and troughed at -$673000.0 in Q3 2025.
- A 5-year average of $185529.4 and a median of $64000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes surged 602.71% in 2023, then tumbled 723.15% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$395000.0 in 2022, then dropped by 3.29% to -$408000.0 in 2023, then jumped by 409.07% to $1.3 million in 2024, then sank by 136.95% to -$466000.0 in 2025, then gained by 25.11% to -$349000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$349000.0, -$466000.0, and -$673000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -349,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Dec 31, 2025 | -466,000.00 |
| Dec 31, 2025 | -466,000.00 |
| Sep 30, 2025 | -673,000.00 |
| Sep 30, 2025 | -673,000.00 |
| Jun 30, 2025 | 943,000.00 |
| Jun 30, 2025 | 943,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 108,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | -429,000.00 |
| Jun 30, 2024 | -429,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | -408,000.00 |
| Dec 31, 2023 | -408,000.00 |